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A B S T R A C T
Objectives: To investigate the localization and progressive changes of cyclic-AMP dependent protein
kinase (cPKA) in the mouse hippocampus at acute stages during and after pilocarpine induced status
epilepticus.
Methods: Pilocarpine induced status epilepticus mice were sacriﬁced 30 min, 2 h or 1 day after the start
of a 7 h lasting status as assessed by video-electroencephalography. Brains were processed for
quantitative immunohistochemistry of hippocampal cPKAb and cPKAg, and immunohistochemical co-
localization of cPKAb and cPKAg with calbindin (CB), calretinin (CR), and parvalbumin (PV).
Results: Based on anatomical and morphological assessment, cPKAb was primarily expressed by
principal cells and cPKAg by interneurons. In CA1, cPKAb co-localized with 76% of CB, 41% of CR, and
95% of PV-immunopositive cells, while cPKAg co-localized with 50% of CB, 29% of CR, and 80% of
PV-immunopositive cells. Upon induction of status epilepticus, cPKAb expression was transiently
reduced in CA1, whereas cPKAg expression was sustainably reduced.
Conclusion: cPKA may play an important role in neuronal hyperexcitability, death and epileptogenesis
during and after pilocarpine induced status epilepticus.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The mammalian protein kinase A (PKA) family consists of four
regulatory and three catalytic subunits, and each subunit is encoded
by a unique gene. Cyclic-AMP dependent protein kinase (cPKA), a
serine–threonine kinase, is involved in a wide range of cellular
functions such as metabolism, transport, cell cycle, and gene
regulation. Furthermore, cPKA is involved in controlling hippocam-
pal neuronal activity,1–4 and has been reported to participate in
maintaining epileptic activity and inducing status epilepticus.5–10
For instance, in tottering mice5 or genetically prone to audiogenic
seizures (GPAS) rats,6 the abnormal elevation of PKA activity has
been demonstrated to contribute to a functional impairment of
GABAA receptor, and be involved in mechanisms of genetic
predisposition to spontaneous seizures. In status epilepticus (SE)§ Supported by research grant (No: NMRC/0960/2005) from the National Medical
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doi:10.1016/j.seizure.2010.06.008model, Niimura et al.7 observed that phosphorylation of NR1by PKA
was depressed relative to controls immediately following SE and
transiently increased above control values upon the termination of
SE. Va´zquez-Lo´pez et al.8 suggested that acute picrotoxin-induced
seizures occurred without an increase in PKA activity in the
hippocampus, but reduced PKA-mediated phosphorylation pro-
tected against picrotoxin seizures by increasing the inhibitory
potential of GABAA receptors. In hippocampal interneurons, it has
been shown that H2 histamine receptor activation negatively
modulates outward currents through Kv3.2-containing potassium
channels by a mechanism involving PKA phosphorylation and PKA
phosphorylation of Kv3.2 lowered the maximum ﬁring frequency of
inhibitory neurons, which in turn negatively modulated high-
frequency population oscillations recorded in principal cell layers.11
However, so far, there is no study to describe detailed localization of
cPKA in the hippocampus, particularly in different subtypes of
calcium binding protein (CBP) (calbindin, CB; calretinin, CR;
parvalbumin, PV) immunopositive interneurons. Furthermore, the
progressive changes of cPKA in the hippocampus at acute stages, i.e.,
within1day, during andafter pilocarpine induced status epilepticus
are also unknown. Therefore, the present study was carried out to
address these issues in order to provide clues for better understand-
ing the roles that cPKAmight play in inducing ormaintaining status
epilepticus, and in neurodegenerative changes at acute stages
during and after pilocarpine induced status epilepticus.vier Ltd. All rights reserved.
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2.1. Video camera and electroencephalography (EEG) monitoring
Tomonitor EEGof the freelymovingmice, a transmitter (TSE, Bad
Homburg, Germany) was ﬁxed on the electrode socket by plug
connection with wires attached to the skull of mice by two screws
(2.3 mm posterior and 2 mm lateral to bregma) 3 days before
pilocarpine induction. The EEG signals were telemetrically received
via HF receiver which passed the signals to the computer. The
duration of EEG monitoring was 24 h starting from 30min before
injection of methyl-scopolamine nitrate. Special telemetry inter-
faces built in the computer decoded and processed the signals from
the receiver and then transferred them to the personal computer.
Signals were then read by the TSE TeleSys data acquisition and
analysis program. Video camera recording was done simultaneous-
ly, so to correlate behavioral changes to EEG data.
2.2. Pilocarpine treatment
B29 male and female mice weighing 25–30 g were used for the
study according to our established procedure.12,13 Mice were given
a single subcutaneous injection of methyl-scopolamine nitrate
(1 mg/kg) 30 min before the injection of either saline in the control
or pilocarpine in the experimental groups. In the latter group, the
mice received a single i.p. injection of 300 mg/kg pilocarpine and
experienced acute SE. In this experiment, 9% animals died during
and after induction. Therefore, they were not included in the
quantitative study. All experimentswere approved by the Tan Tock
Seng Hospital – National Neuroscience Institute Institutional
Animal Care and Use Committee. In the handling and care of all
animals, the guidelines of the NIH for animal research were strictly
followed. Efforts were made throughout the study to minimize
animal suffering and to use the minimum number of animals.
2.3. Immunohistochemical study of the expression of cPKAb and
cPKAg
A total of 24micewas used for immunohistochemical study. Six
mice were killed at each of the survival intervals after beginning of
the status epilepticus, i.e. at 30 min, 2 h during pilocarpine induced
status epilepticus, and at 1 day after pilocarpine induced status
epilepticus. Six mice with saline instead of pilocarpine injection
were killed at 30 min, 2 h and 1 day for the control group.
Following deep anaesthesia with chloral hydrate (0.4 g/kg), the
mice were perfused transcardially with 100 ml of saline initially,
followed by 100 ml of 4% paraformaldehyde in 0.1 M PB
(phosphate buffer, pH 7.4) for 15 min. After perfusion, the brain
of each mouse was removed, and kept overnight in 30% sucrose in
0.1 M phosphate buffer. Coronal sections at 40 mm thickness were
cut in a cryostat (HM505E, Microm; Zeiss, Oberkochen, Germany).
Serial sections were transferred to different wells of a 24-well
tissue culture dish for controls and PKA immunohistochemical
reaction. For immunohistochemical study, free-ﬂoating sections
were treated with 2% lyophilized bovine serum albumin in TBS–TX
(Tris-buffered saline with 1% Triton X-100, PH 7.6) (for cPKAb and
cPKAg) for 2 h at room temperature. All sectionswere thenwashed
in TBS–TX and placed overnight at room temperature in the
primary goat antibodies against cPKAb (1:500 in TBS–TX) and
cPKAg (1:1000 in TBS–TX) (Santa Cruz Biotechnology, CA, USA).
After incubation, sections were washed in TBS–TX and placed for
2 h in biotinylated anti-goat IgG secondary antibodies (1:400 in
TBS–TX). After threewashes in TBS–TX, the sectionswere placed in
avidin–biotin complex (ABC) reagent (Vector Laboratories, Bur-
lingame, CA, USA, 1:100 in TBS–TX) for 2 h. Theywere thenwashed
in 0.1 M Tris buffer (TB, pH 7.6) and reacted in a solution of 0.012%H2O2 and 0.05% 3,30-diaminobenzidine (Sigma, St. Louis, MO, USA)
in TB for 3–5 min and washed in TB, mounted, dehydrated and
covered. In the negative control section, the primary antibodies
were omitted.
2.4. Double-labeling immunoﬂuoresence microscopy
Double-labeling immunoﬂuoresence microscopy was carried
out to co-localize cPKAb and cPKAg with different subtypes of
calcium binding protein (calbindin, calretinin and parvalbumin
from Chemicon International Inc., CA, USA) in hippocampal
neurons. For this study, tissue sections from six control mice
were washed in 0.1 M TBS–TX and placed overnight in primary
antibodies (cPKAb: 1:500, cPKAg: 1:1000, calbindin: 1:2000,
calretinin: 1:1500, parvalbumin: 1:1500). After incubation, sec-
tions were washed in TBS–TX and placed for 4–6 h in Cy3-
conjugated donkey anti-goat IgG (1:200, Chemicon International
Inc., CA, USA), followed by incubation with FITC-conjugated goat
anti-mouse IgG (1:200, Chemicon International Inc., CA, USA) for
4–5 h. The sections were then mounted, dried, and covered with
FluorSaveTM Reagent (Calbiochem, San Diego, CA, USA) to retard
fading, and examined with an Olympus Fluoview FV500 (Olympus
Corporation, Tokyo, Japan) confocal laser scanning biological
microscope.
2.5. Cell counting and statistical analysis
Cell counting was carried out using the Image-Pro Plus
system (Media Cybernetics, Silver Spring, MD, USA). The cPKAb
and cPKAg immunopositive neuronal proﬁles (deﬁned by neuro-
anatomical and morphological characteristics without evidence of
co-localization with neuronal marker) in the strata oriens,
radiatum, lacunosum moleculare, granulosum and in the hilus
of the dentate gyrus were counted and indicated as a number per
square millimeter. In the stratum pyramidale of CA1, the intensity
value was measured and was normalized to the intensity value of
corpus callosum. 3–5 sections (the intersection distance is
40 mm  8mm = 320mm) of the dorsal hippocampus from each
animal were used for cell counting or intensity measurement.
Immunoﬂuorescent neurons were counted under the confocal
microscope, and the ratios of the number of double-labeled
neurons to all the calbindin-, calretinin- or parvalbumin labeled
neurons were obtained. For every section (3–5 sections for every
animal), all calbindin, calretinin or parvalbumin immunopositive
cells in the respective areas were counted. To avoid the false
immunopositive cell counting, double-labeled cells were con-
ﬁrmed under high magniﬁcation (400) with two different ﬁlters.
Each cell was also tilted at two vertical planes in order to conﬁrm
that the yellow colorwas produced by the red and green labeling in
the same cell instead of two overlapped cells with different colors.
All the data were then subjected to statistical analysis by one-way
ANOVA followed by Student–Newman–Keuls posthoc multiple
comparisons.
3. Results
3.1. Behavioral and EEG monitoring
In the mouse model, pilocarpine-induced behavioral changes
include hypoactivity, tremor, head bobbing, and myoclonic
movements of the limbs progressing to recurrent myoclonic
convulsions with rearing, falling, and status epilepticus. The onset
of continuous epileptic spiking activity, which was considered to
be a marker for the onset of status epilepticus, was found at
28.72  10.84 min after pilocarpine injection. The continuous
epileptic spiking activity (>0.5 Hz) lasted for about 7.23  1.59 h.
[(Fig._1)TD$FIG]
Fig. 1. Immunocytochemical staining shows cPKAb (A) and cPKAg (B) immunopositive product in the hippocampus of the control mice. Moderate cPKAb immunopositive
product is localized in the stratum pyramidale (SP) of CA1-3 areas and in the stratum granulosum (SG) of the dentate gyrus. Weak cPKAb immunopositive product is located
in the stratum lucidum of CA3 area (arrows). Moderately to strongly stained cPKAg (B) immunopositive product is localized in the hilus andmolecular layer (asterisks) of the
dentate gyrus and in the stratum lucidum (arrows) of CA3 area. Scale bar = 200 mm, also applies to (A).
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In mouse hippocampus, moderately to strongly stained
cPKAb (Figs. 1A and 2A) or cPKAg (Figs. 1B and 2E)
immunopositive neurons were found in the strata oriens,
radiatum and lacunosum moleculare of the CA1-3 area, and in
the hilus of the dentate gyrus (Fig. 3A for cPKAb and E for
cPKAg). cPKAb immunopositive neurons were also demonstrat-
[(Fig._2)TD$FIG]Fig. 2. cPKAb (A–D) immunopositive product in the stratum pyramiale of the CA1 are
epilepticus (C) compared to the control (A), but returns back at 1 day after pilocarpine i
immunopositive neurons decreases at 30 min (B) and 2 h during pilocarpine induced s
decreases at 30 min (F), 2 h during (G) and 1 day after (H) pilocarpine induced status eped in the stratum pyramidale of CA1-3 area and the stratum
granulosum of the dentate gyrus (Fig. 1A, 2A and 3A).
Moderately stained cPKAb immunopositive product was also
localized in the stratum lucidum of CA3 area where mossy
ﬁbers and terminals were located (Fig. 1A). Strong cPKAg
immunopositive product appeared in the molecular layer and
hilus of the dentate gyrus and in the stratum lucidum of CA3
area (Fig. 1B).a decreases signiﬁcantly at 30 min (B) and 2 h during pilocarpine induced status
nduced status epilepticus (D). In different strata of CA1 area, the number of cPKAb
tatus epilepticus (C), while the number of cPKAg (E–H) immunopositive neurons
ilepticus compared to the control (E). (H) Scale bar = 100 mm, also applies to (A–G).
[(Fig._3)TD$FIG]
Fig. 3. The number of cPKAb (A–D) and cPKAg (E–H) immunopositive neurons decreases progressively in the hilus of the dentate gyrus from30 min during (cPKAb: B; cPKAg:
F) to 1 day after (cPKAb: D; cPKAg: H) pilocarpine induced status epilepticus. (H) Scale bar = 200 mm, also applies to (A–G).
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experimental mice at acute stages during and after pilocarpine
induced status epilepticus
3.3.1. CA1 area
3.3.1.1. Stratum pyramidale. Compared to the control mice
(Fig. 2A), the number of cPKAb immunopositive neurons reduced
signiﬁcantly at both 30 min (Fig. 2B) (P < 0.05, Fig. 4D) and 2 h
during pilocarpine induced status epilepticus (Fig. 2C) (P < 0.01,
Fig. 4D), but returned back at 1 day after pilocarpine induced status
epilepticus (Fig. 2D, P > 0.05, Fig. 4D). At all the time points, cPKAg
immunopositive product was almost undetectable in the stratum
pyramidale of CA1 area (Fig. 2E–H).
3.3.1.2. Strata oriens and radiatum. At 30 min (Fig. 2B) and 2 h
(Fig. 2C) during pilocarpine induced status epilepticus, the number
[(Fig._4)TD$FIG]Fig. 4. Histograms showing the progressive changes of cPKAb or cPKAg immunopos
epilepticus. n = 18 observations from 6 rats. *p < 0.01, +p < 0.05 compared with the c
immunpositive product is indicated as a grey value. Note that the increase of intensity
coupled.of cPKAb immunopositive neurons also decreased signiﬁcantly
compared with the control (Fig. 2A) (P < 0.01, Fig. 4A and B), but it
was similar to the control at 1 day after pilocarpine induced status
epilepticus (Fig. 2D) (P > 0.05, Fig. 4A and B). In the two layers, the
number of cPKAg immunopositive neurons reduced signiﬁcantly
at 30 min (Fig. 2F), 2 h during (Fig. 2G) and 1 day after pilocarpine
induced status epilepticus (Fig. 2H) compared to the control
(Fig. 2E) (P < 0.05, Fig. 4A and B). However, no signiﬁcant
difference was shown for PKAg immunopositive neurons among
30 min, 2 h during and 1 day after pilocarpine induced status
epilepticus (P > 0.05, Fig. 4A and B).
3.3.1.3. Stratum lacunosum moleculare. At all the time points
during (30 min: Fig. 2B and F; 2 h: Fig. 2C and G) and after (1
day: Fig. 2D and H) pilocarpine induced status epilepticus, the
number of both cPKAb (Fig. 2B–D) and cPKAg (Fig. 2F–H)
immunopositive neurons in the stratum lacunosum moleculareitive neurons/product within 1 day during and after pilocarpine induced status
ontrol. Cell density is indicated as a number per square millimeter; intensity of
(grey value) indicates the decrease of protein expression, the two are negatively
[(Fig._5)TD$FIG]
Fig. 5. Double-labeling immunoﬂuoresence microscopy shows co-localization (yellow, arrows) of cPKAb (A–C, red) or cPKAg (D–F, red) with CB (A, D, green), CR (B, E, green)
or PV (C, F, green) in CA1 area of the hippocampus of the control mouse. In the hilus of the dentate gyrus, co-localization (yellow, arrows) of cPKAb (G–I, red) or cPKAg (J–L,
red) with CB (G, J, green), CR (H, K, green) or PV (I, L, green) is also indicated. Note that there is not co-localization of cPKA with CB (G–J, green) in hilar neurons. (F) Scale
bar = 100mm, also applies to (A–E); (L) scale bar = 100 mm, also applies to (G–K). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of the article.)
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(cPKAb: Fig. 2A; cPKAg: Fig. 2E).
3.3.2. Dentate gyrus
3.3.2.1. Stratum granulosum. cPKAb immunopositive product in
the stratumgranulosumat 30 min (Fig. 3B), 2 h during (Fig. 3C) and
1 day after (Fig. 3D) pilocarpine induced status epilepticus was
similar to the control mice (Fig. 3A). No obvious change of cPKAg
immunopositive product was observed in this layer among
different groups of mice (control: Fig. 3E; 30 min: Fig. 3F; 2 h:
Fig. 3G; 1 day: Fig. 3H).
3.3.3. Hilus
In the hilus of the dentate gyrus, drastic reduction of both
cPKAb or PKAg immunopositive neurons occurred at 30 min
(cPKAb: Fig. 3B; cPKAg: Fig. 3F) and 2 h during (cPKAb: Fig. 3C;
cPKAg: Fig. 3G) and 1 day after (cPKAb: Fig. 3D; cPKAg: Fig. 3H)
pilocarpine induced status epilepticus compared to the control
mice (cPKAb: Fig. 3A; cPKAg: Fig. 3E) (P < 0.01/0.05, Fig. 4C).Table 1
Percentage of calbindin, calretinin or parvalbumin and PKA or PKA double-labeled
neurons to the total calbindin, calretinin or parvalbumin immunopositive neurons
in CA1 area and in the hilus of the dentate gyrus in the control animals by double
immunoﬂuoresence labeling.






PKAg+PV 79.835.04 56.337.393.4. Double-labeling immunoﬂuorescence microscopy
In CA1 area of the hippocampus in the control mice, most of
calbindin (CB; Fig. 5A) or parvalbumin (PV; Fig. 5C) immunopo-
sitive neuronswere cPKAb (Fig. 5A–C) immunopositive, only 40.8%
of CR (CR; Fig. 5B) immunopositive neurons were cPKAb
immunopositive. Most PV (Fig. 5F) immunopositive neurons
expressed cPKAg (Fig. 5D–F), while 49.5% CB (Fig. 5D) immuno-
positive neurons and 28.8% CR (Fig. 5E) immunopositive neurons
were cPKAg positive (Table 1).
In the dentate gyrus, cPKAb was co-localized with CB in the
stratum granulosum (Fig. 5G). However, there was no co-
localization of cPKAg with CB (Fig. 5J). In the hilus of the dentate
gyrus, about 79.5% and 79.3% of CR immunopositive neurons
expressed cPKAb (Fig. 5H) and cPKAg (Fig. 5K) respectively.
Almost all the PV immunopositive neurons were cPKAb immu-
nopositive in the hilus and the stratum granulosum of the dentate
gyrus (Fig. 5I). However, only 56.3% of PV immunopositive neurons
were cPKAg immunopositive (Fig. 5J–L).
4. Discussion
4.1. cPKA in the mouse hippocampus
cPKAhasbeen involved in regulationofGABAA,
14,15 kainate,16H2
histamine,11 NMDA receptor,7,17 AMPA18 and type 1 cannabinoid19
receptors. It also modulates slow Ca2+-activated K+ current by
norepinephrine, serotonin, histamine,20 corticotropin releasing
factor, vasoactive intestinal peptide, calcitonin gene-related pep-
tide,1 endogenous PGE2,3 and dopamine21 in hippocampal neurons.
In situ hybridization has shown that the mRNA expression
pattern of cPKAa varied from that of cPKAb in the hippocampus.
mRNA encoding cPKAa was equally distributed between the
J.X. Liu et al. / Seizure 19 (2010) 414–420 419dentate gyrus and pyramidal cell layers CAl-3. In contrast,
although cPKAb expression was high in the dentate gyrus, little
cPKAb mRNA was observed in the CAl-3 cell layers.22 It is
inconsistent with our study showing moderately to strongly
expressed cPKAb protein in the stratum pyramidale of CA1-3,
suggesting that gene and protein expressions may not be always
matched. In subcellular elements of cultured hippocampal
neurons, cPKA was co-localized with microtubules in dendrites
as well as with the actin ﬁlaments in growth cones, which
indicated that PKAwas anchored to actin andMT cytoskeletons.23
However, so far, there is still no systemic study of the localization
of cPKA proteins in different areas of hippocampus and different
types of hippocampal neurons. In the present study, we showed
that cPKAb was expressed by hippocampal principal and hilar
cells, interneurons, and mossy ﬁbers, cPKAg was localized in
hippocampal interneurons, hilar cells,mossy ﬁbers andmolecular
layer of the dentate gyrus. The study therefore provides ﬁrst
neuroanatomical basis for understanding the mechanism of not
only functional changes of hippocampal principal cells and
interneurons regulated by cPKA,1,2 but also the selective defect
in mossy ﬁber LTP after ablation of gene targeting on cPKA24 as
cPKAb is localized in mossy ﬁbers and terminals in the stratum
lucidum of CA3 area.
Double-labeling immunohistochemistry revealed that most of
PV immunopositive neurons expressed cPKAb or cPKAg in CA1
area and in the dentate gyrus, and most of CR immunopositive
neurons in the hilus of the dentate gyrus were cPKAb or cPKAg
immunopositive. It therefore suggests that cPKA may play a very
important role in regulation of the activity of PV interneurons
(basket cells) which innervate the perisomatic area of principal
cells and hilar mossy cells labeled by CR.
4.2. Progressive changes of cPKA in hippocampal neurons during and
after pilocarpine induced status epilepticus
Bracey et al.25 demonstrated an increase in PKA activity in
cortical structures, but not in hippocampus at later stages after
pilocarpine induced status epilepticus. The present study may
therefore provide some clues for better understanding the
mechanism of PKA-related neuronal excitability and epileptogen-
esis during and after status epilepticus.
It has been reported that cPKA inhibits the function of brain
GABAA receptors,
14 and is involved in GABAA receptor dysfunction
in CA1 pyramidal neurons following chronic benzodiazepine
treatment.15 PKA phosphorylation of Kv3.2-containing potassium
channels in inhibitory interneurons is also involved in H2
histamine receptor modulated outward currents, which lowered
the maximum ﬁring frequency of inhibitory neurons, and in turn
negatively modulated high-frequency population oscillations
recorded in principal cell layers.11 In tottering mouse brain, an
abnormal elevation of PKA activity contributes to an impairment of
GABAA receptor function which may play a role in induction of the
seizures.5 However, reduced PKA-mediated phosphorylation
protects against picrotoxin seizures by increasing the inhibitory
potential of GABAA receptors.
8 In the present study 30 min and 2 h
during pilocarpine induced status epilepticus, fewer cPKAb
immunopositive principal cells and cPKAb or cPKAg immunopo-
sitive interneurons in CA1 area, and fewer cPKAb or cPKAg
immunopositive hilar neurons in the dentate gyrus were observed,
which in fact was not caused by neuronal loss,26 suggesting a
down-regulation of cPKA may reﬂect a compensatory mechanism
to reduce impairment of GABAA receptor function in the
hippocampus. In the hilus of the dentate gyrus, signiﬁcant
reduction of cPKAb or cPKAg immunopositive neurons at 1 day
after pilocarpine induced status epilepticus may be due to the loss
of hilar neurons which has been reported previously.27,28Many of previous studies suggested that cAMP/PKA signaling
could modulate excitatory synaptic transmission in the hippo-
campus. Activating cAMP/PKA signaling pathway enhanced
whole-cell current responses to glutamate, and these responses
were blocked by a speciﬁc peptide inhibitor of PKA.29 Also, Sp-
cAMPS, a phosphodiesterase-resistant activator of PKA, was
demonstrated to potentiate glutamatergic receptor currents in
cultured hippocampal neurons.16 Furthermore, single-channel
activity monitored in the presence of puriﬁed cPKA also showed
that these subunits increased opening frequency and mean open
time of glutamate receptor channels.29 Hence, the down-regula-
tion of PKAb in principal cell of CA1 area at early stage during
pilocarpine induced status epilepticus may reduce the presynaptic
glutamate release and decreases phosphorylation on serine and
threonine residues of GABAA receptors, which keep GABA
receptors consistently below their full inhibitory potential30
leading to the hyperexcitability of CA1 pyramidal neurons. In
the hilus of the dentate gyrus, as most of CR (which is a marker for
hilar mossy cells) immunopositive neurons were cPKAb or cPKAg
immunopositive, down-regulation of cPKAb or cPKAg at 30 min
and 2 h during pilocarpine induced status epilepticus may reﬂect a
compensatory neuroprotective mechanism to prevent the loss of
mossy cells in the dentate gyrus.
In the present study, the quantitative study of protein
expression of cPKA has been explored only in dorsal hippocampus
instead of thewhole hippocampus. Further studymay be needed to
show if similar changes occur in the ventral hippocampus.
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